Lucentis approved for diabetic retinopathy

February 9, 2015

(HealthDay)—A drug to treat the most common eye disease among diabetics has been approved by the U.S. Food and Drug Administration.

Lucentis (ranibizumab) has been sanctioned to treat , the leading cause of blindness among adults in the United States, the FDA said in a news release. In 2008, one-third of diabetic adults 40 or older had some form of diabetic retinopathy, the agency said.

Lucentis, a once-monthly injection, is designed to be used with other therapies to control blood sugar, blood pressure and cholesterol, the FDA said. In some people with diabetic retinopathy who also have , can grow and rupture on the eye's retina, leading to severe vision loss or blindness.

The most common side effects of Lucentis include bleeding of the eye's conjunctiva, eye pain, eye floaters and increased eye pressure. More serious adverse reactions could include eye infection and retinal detachment, the FDA said.

Lucentis had been approved previously to treat other forms of macular edema, and .

The drug is marketed by San Francisco-based Genentech, a subsidiary of Roche.

Explore further: FDA approves drug to treat diabetic macular edema

More information: To learn more about this approval, visit the FDA.

Related Stories

FDA approves drug to treat diabetic macular edema

August 13, 2012
The U.S. Food and Drug Administration today announced its approval of Lucentis (ranibizumab injection) for the treatment of diabetic macular edema, or DME, an eye condition in people with diabetes that causes blurred vision, ...

In mice and men: Laser treatment reverses effects of early age-related macular degeneration

February 2, 2015
A new technique reported in the February 2015 issue of The FASEB Journal suggests that during early stages, it might be possible to reverse age-related macular degeneration, a leading cause of blindness that is currently ...

Diabetes leading to blindness in many people

November 30, 2012
Diabetes is the leading cause of new cases of blindness among adults 20 to 74 years old. Dr. Michael Grodin, co-director of retinal services and director of clinical research at Katzen Eye Group, with locations around Baltimore, ...

Sharp rise in diabetic eye disease makes American Diabetes Month ever more important

November 7, 2012
Diabetes is the leading cause of blindness among working-age adults in the United States. According to recent studies funded by the National Eye Institute (NEI), diabetic retinopathy, one of the most common and debilitating ...

FDA warns of another compounding pharmacy recall

March 20, 2013
(AP)—The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling syringes of the Roche drug Avastin after receiving reports of eye infections among patients.

Blood vessel research offers insights into new treatments for eye diseases

May 27, 2014
(Medical Xpress)—Leukaemia drugs could help to improve treatments for blindness caused by abnormal blood vessel growth in the eye, finds new UCL research. The study, published in the Journal of Experimental Medicine, raises ...

Recommended for you

FDA approves contact lenses that shade the sun

April 13, 2018
The lives of contact lens wearers just got a whole lot easier.

New glaucoma treatment could ease symptoms while you sleep

April 11, 2018
Eye drops developed by UBC researchers could one day treat glaucoma while you sleep - helping to heal a condition that is one of the leading causes of blindness around the world.

Researchers test stem cell-based retinal implant for common cause of vision loss

April 4, 2018
Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal implant is feasible for use in people with advanced dry age-related ...

Post-Ebola cataract surgery can safely restore vision

April 4, 2018
Cataract surgery can be safely performed on Ebola virus disease survivors with impaired vision, Emory Eye Center ophthalmologists and 40 colleagues around the world report.

Older adults with small social networks less likely to get cataract surgery

March 9, 2018
Close family relationships and a strong social network may help older adults see the world better—literally.

A retinal implant that is more effective against blindness

March 9, 2018
EPFL researchers have developed a new type of retinal implant for people who have become blind due to the loss of photoreceptor cells in their retinas. The implant partially restores their visual field and can significantly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.